Nanning Sugar Industry Co. Ltd. – a large scale enterprise in the sugar business for the Pharmaceutical needs and other diversified businesses based on sugar

It was privilege for the team of World Pharma Today to interact with the officials of Nanning Sugar Industry Co. Ltd. at API China 2018.

The 80th China International Pharmaceutical Materials, Intermediates, Packaging & Equipment Fair held at Hall No. 7.2 & 8.2 of the Massive National Convention and Exhibition Center (Shanghai) alongside PHARMCHINA, CMEF – China International Medical Equipment Fair and tHIS – The Healthcare Industry Summit conducted in different halls from 11th to 13th April 2018.

Nanning Sugar Industry Co. Ltd. is one of the top 10 enterprises in the China’s lightening sugar industry market. With 47.71% of State-owned shares it is currently the largest state-controlled listed companies in the domestic sugar Industry. With the processing capacity of 700,000 tones of annual mechanized sugar operating through its seven directly-owned plants and more than 4,400 employees, it is a large scale enterprise in the sugar business that develops diversified businesses based on sugar. With around 50 products in the company that are being produced over the past 5 years, the company also manufacturing and supply special sugar for the medical use to the Pharmaceutical industry.

Standing at a new starting point, Nanning Sugar Industry Co., Ltd. is committed to the mission of “creating quality sugar and sharing sweet life”, adhering to the core values of “respected companies, trustworthy partners”, and establishing “best stock” and “big increase”. The strategic development goal of “Quanta Nannan Sugar” is to focus on the main sugar industry and strive to make Nanning Sugar as a leading company , with superior advantages and diversified operations.

The pharmaceutical industry requires special sugar which is antibacterial and Nanning Sugar Industry is the sole manufacturer for the sugar of their kind. Their product has been approved by the regulatory authorities and they expect that more pharmaceutical companies will come up in the near future to adopt their form of sugar which they presently supply through agents to various distributing companies in the pharmaceutical sector.

While the interview we observed a very good thing about them that they know about their technology and acknowledge the fact that it’s a new technology and they are still in the process of learning and expanding, this self-analysis behavior gets this company added in our list of those companies from whom we expect great growth in the near future.

Because they hold the monopoly in the market for the technology they have their growth plans focused on expanding their business through acquisitions. They want to increase the production by 5 times from 20,000 tons to 100,000 tons for which they want to acquire manufacturing units to implement their technology and operations so that they will be able to increase their reach and get more recognition for their valuable product.